What are the Bethesda categories for thyroid cytology?
TBSRTC 2023 recommends the following as the 6 reporting category names: (i) nondiagnostic; (ii) benign; (iii) atypia of undetermined significance (AUS); (iv) follicular neoplasm; (v) suspicious for malignancy (SFM); and (vi) malignant (Table 1)..
What are the categories of Bethesda classification?
Fine-needle aspiration cytology (FNAC) of thyroid is the initial screening test for thyroid nodules.
The Bethesda system classifies thyroid FNAC into six categories.
Each category is linked to a malignancy risk and has a recommended clinical management.Feb 16, 2018.
What are the classification of Bethesda cytopathology?
The most important is the assignment of a single name for each of the 6 diagnostic categories: (i) nondiagnostic; (ii) benign; (iii) atypia of undetermined significance; (iv) follicular neoplasm; (v) suspicious for malignancy; and (vi) malignant..
What is Bethesda category?
This meeting resulted in a standardized thyroid cytopathology reporting method called the “Bethesda System.” The Bethesda System identifies six diagnostic categories on thyroid nodule cytopathology: nondiagnostic or unsatisfactory; benign; atypia of undetermined significance (AUS) or follicular lesion of undetermined .
What is FNAC Bethesda classification?
Fine-needle aspiration cytology (FNAC) of thyroid is the initial screening test for thyroid nodules.
The Bethesda system classifies thyroid FNAC into six categories.
Each category is linked to a malignancy risk and has a recommended clinical management..
What is the Bethesda classification system?
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, used for reporting Pap smear results..
What is the Bethesda system of classification?
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, used for reporting Pap smear results.
It was introduced in 1988 and revised in 1991, 2001, and 2014..
- Low-grade squamous intraepithelial lesion (LSIL) encompassing HPV‡ infection or mild dysplasia (CIN .
.- High-grade squamous intraepithelial lesion (HSIL) encompassing moderate (CIN 2) and severe dysplasia (CIN 3/CIS), noting whether the lesion has features suggesting invasion.
Squamous cell carcinoma.
